INHIBIDOR DE LA FIBRINOLISIS ACTIVADO POR TROMBINA (TAFI): NEXO ENTRE LA COAGULACION Y LA FIBRINOLISIS
Columnista Experto de SIIC Jovan P Antovic
en colaboración con
Fecha de aprobación: 6 de septiembre, 2005
Primera edición en siicsalud:
10 de abril, 2006
Sección Artículos originales,
subsección
Expertos de Iberoamérica,
página
/des/expertocompleto.php/76185
Especialidad principal:
Bioquímica
Especialidades relacionadas:
Diagnóstico por Laboratorio,Hematología,Medicina Interna,
Antovic JP, Hannerz J, Nekludov M, Blombäck M. TAFI antigen could not be detected in cerebrospinal fluid, Thromb Haemost 93:178-9, 2005
Antovic JP, Schulman S, An SSA, Greenfield R, Blömback M. Does enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with hemophilia A, B and Von Willebrand disease, Scand J Lab Clin Invest 64:745-52, 2004
Antovic JP, Antovic A, Sten-Linder M, Wramsby M, Blombäck M. Overall hemostatic potential (OHP) assay – a possible tool for determination of prothtrombotic pattern in FXII deficiency, J Thromb Haemost 2:2058-60, 2004
Antovic JP. Thrombin activatable fibrinolysis inhibitor (TAFI) a link between coagulation and fibrinolysis (review), Clin Lab 49:475-86, 2003
Antovic JP, Antovic A. Does recombinant factor VIIa apart from overall hemostasis regulate TAFI dependent fibrinolysis– in vitro analysis using overall hemostasis potential (OHP) assay, Thromb Haemost 90:620-8, 2003
Antovic JP, Yngen M, Östenson CG, Antovic A, Wallen NH, Jorneskog G, Blombäck M. Thrombin activatable fibrinolysis inhibitor (TAFI) and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications, Blood Coag Fibrinolys 14:551-6, 2003
Jovan P Antovic
